ANALYSIS BY BUSINESS SEGMENT | Revenue | Adjusted operating profit | ||||
2022 | 2023 | 2024 | 2022 | 2023 | 2024 | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Risk | 2,909 | 3,133 | 3,245 | 1,078 | 1,165 | 1,228 |
Scientific, Technical & Medical | 2,909 | 3,062 | 3,051 | 1,100 | 1,165 | 1,172 |
Legal | 1,782 | 1,851 | 1,899 | 372 | 393 | 412 |
Exhibitions | 953 | 1,115 | 1,239 | 162 | 319 | 398 |
Sub-total | 8,553 | 9,161 | 9,434 | 2,712 | 3,042 | 3,210 |
Unallocated central costs and other operating | ||||||
items | - | - | - | (29) | (12) | (11) |
Total | 8,553 | 9,161 | 9,434 | 2,683 | 3,030 | 3,199 |
2022 | Scientific, Technical | ||||
Risk | & Medical | Legal | Exhibitions | Total | |
Revenue by geographical market | |||||
North America | 2,317 | 1,391 | 1,213 | 180 | 5,101 |
Europe | 384 | 614 | 357 | 445 | 1,800 |
Rest of world | 208 | 904 | 212 | 328 | 1,652 |
Total revenue | 2,909 | 2,909 | 1,782 | 953 | 8,553 |
Revenue by format | |||||
Electronic | 2,890 | 2,573 | 1,582 | 67 | 7,112 |
Face-to-face | 11 | 5 | 10 | 886 | 912 |
Print | 8 | 331 | 190 | - | 529 |
Total revenue | 2,909 | 2,909 | 1,782 | 953 | 8,553 |
Revenue by type | |||||
Subscriptions | 1,135 | 2,139 | 1,381 | - | 4,655 |
Transactional | 1,774 | 770 | 401 | 953 | 3,898 |
Total revenue | 2,909 | 2,909 | 1,782 | 953 | 8,553 |
2023 | Scientific, Technical | ||||
Risk | & Medical | Legal | Exhibitions | Total | |
Revenue by geographical market | |||||
North America | 2,476 | 1,439 | 1,254 | 217 | 5,386 |
Europe | 429 | 666 | 386 | 427 | 1,908 |
Rest of world | 228 | 957 | 211 | 471 | 1,867 |
Total revenue | 3,133 | 3,062 | 1,851 | 1,115 | 9,161 |
Revenue by format | |||||
Electronic | 3,111 | 2,762 | 1,667 | 85 | 7,625 |
Face-to-face | 14 | 7 | 9 | 1,030 | 1,060 |
Print | 8 | 293 | 175 | - | 476 |
Total revenue | 3,133 | 3,062 | 1,851 | 1,115 | 9,161 |
Revenue by type | |||||
Subscriptions | 1,255 | 2,261 | 1,460 | - | 4,976 |
Transactional | 1,878 | 801 | 391 | 1,115 | 4,185 |
Total revenue | 3,133 | 3,062 | 1,851 | 1,115 | 9,161 |
2024 | Scientific, Technical | ||||
Risk | & Medical | Legal | Exhibitions | Total | |
Revenue by geographical market | |||||
North America | 2,563 | 1,411 | 1,290 | 231 | 5,495 |
Europe* | 443 | 656 | 399 | 527 | 2,025 |
Rest of world | 239 | 984 | 210 | 481 | 1,914 |
Total revenue | 3,245 | 3,051 | 1,899 | 1,239 | 9,434 |
Revenue by format | |||||
Electronic | 3,226 | 2,785 | 1,730 | 83 | 7,824 |
Face-to-face | 16 | 6 | 11 | 1,156 | 1,189 |
Print | 3 | 260 | 158 | - | 421 |
Total revenue | 3,245 | 3,051 | 1,899 | 1,239 | 9,434 |
Revenue by type | |||||
Subscriptions | 1,260 | 2,250 | 1,515 | - | 5,025 |
Transactional | 1,985 | 801 | 384 | 1,239 | 4,409 |
Total revenue | 3,245 | 3,051 | 1,899 | 1,239 | 9,434 |
ANALYSIS OF REVENUE BY GEOGRAPHICAL ORIGIN | 2022 | 2023 | 2024 |
GBPm | GBPm | GBPm | |
North America | 5,002 | 5,325 | 5,461 |
Europe | 2,974 | 3,117 | 3,270 |
Rest of world | 577 | 719 | 703 |
Total | 8,553 | 9,161 | 9,434 |
ANALYSIS BY BUSINESS |
Expenditure on |
|||||||||||
SEGMENT |
acquired goodwill and |
Capital expenditure |
Amortisation of acquired |
Total depreciation and |
||||||||
| intangible assets |
additions |
intangible assets |
other amortisation |
|||||||||
2022 |
2023 |
2024 |
2022 |
2023 |
2024 |
2022 |
2023 |
2024 |
2022 |
2023 |
2024 |
|
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
|
Risk |
155 |
79 |
- |
122 |
139 |
148 |
204 |
194 |
184 |
94 |
92 |
99 |
Scientific, Technical & |
||||||||||||
Medical |
206 |
3 |
8 |
103 |
108 |
104 |
60 |
59 |
44 |
119 |
136 |
125 |
Legal |
33 |
42 |
145 |
186 |
193 |
203 |
12 |
11 |
15 |
229 |
247 |
256 |
Exhibitions |
- |
8 |
65 |
28 |
37 |
29 |
20 |
16 |
15 |
49 |
39 |
45 |
Total |
394 |
132 |
218 |
439 |
477 |
484 |
296 |
280 |
258 |
491 |
514 |
525 |
ANALYSIS OF NON-CURRENT ASSETS BY GEOGRAPHICAL LOCATION |
2023 |
2024 |
GBPm |
GBPm |
|
North America |
9,149 |
9,131 |
Europe |
2,141 |
2,259 |
Rest of world |
459 |
438 |
Total |
11,749 |
11,828 |
RECONCILIATION OF OPERATING PROFIT TO ADJUSTED OPERATING PROFIT |
2022 |
2023 |
2024 |
GBPm |
GBPm |
GBPm |
|
Operating profit |
2,323 |
2,682 |
2,861 |
Adjustments: |
|||
Amortisation of acquired intangible assets |
296 |
280 |
258 |
Acquisition and disposal related items |
62 |
56 |
69 |
Reclassification of tax in joint ventures and associates |
4 |
12 |
12 |
Reclassification of finance income in joint ventures and associates |
(2) |
- |
(1) |
Adjusted operating profit |
2,683 |
3,030 |
3,199 |
2022 |
2023 |
2024 |
||
Note |
GBPm |
GBPm |
GBPm |
|
Total staff costs |
5 |
2,906 |
3,108 |
3,120 |
Depreciation and amortisation |
||||
Amortisation of acquired intangible assets |
14 |
294 |
279 |
258 |
Share of joint ventures and associates' amortisation of acquired |
||||
intangible assets |
2 |
1 |
- |
|
Amortisation of acquired intangible assets including joint ventures and |
||||
associates' share |
296 |
280 |
258 |
|
Amortisation of internally developed intangible assets |
14 |
309 |
330 |
364 |
Depreciation of property, plant and equipment |
16 |
47 |
43 |
34 |
Depreciation of right-of-use assets |
63 |
65 |
50 |
|
Pre-publication amortisation |
72 |
76 |
77 |
|
Total depreciation and other amortisation |
2 |
491 |
514 |
525 |
Total depreciation and amortisation (including amortisation of |
||||
acquired intangibles) |
787 |
794 |
783 |
|
Other expenses and income |
||||
Cost of sales including pre-publication costs and inventory expenses |
3,045 |
3,216 |
3,300 |
|
Short-term and low value lease expenses |
19 |
18 |
16 |
2022 |
2023 |
2024 |
|
GBPm |
GBPm |
GBPm |
|
Auditor’s remuneration |
|||
Payable to the auditors of RELX PLC |
0.9 |
0.9 |
0.9 |
Payable to the auditors of the Group’s subsidiaries |
8.4 |
8.0 |
7.2 |
Audit services |
9.3 |
8.9 |
8.1 |
Audit-related assurance services |
0.6 |
0.5 |
0.4 |
Other assurance services* |
- |
0.2 |
0.5 |
Total auditor’s remuneration |
9.9 |
9.6 |
9.0 |
2022 | 2023 | 2024 | ||
Note | GBPm | GBPm | GBPm | |
Staff costs | ||||
Wages and salaries | 2,453 | 2,636 | 2,630 | |
Social security costs | 257 | 274 | 280 | |
Pensions | 6 | 150 | 142 | 144 |
Share based remuneration | 46 | 56 | 66 | |
Total staff costs | 2,906 | 3,108 | 3,120 |
NUMBER OF PEOPLE EMPLOYED: FULL-TIME EQUIVALENTS* | At 31 December | Average during the year | ||||
2022 | 2023 | 2024 | 2022 | 2023 | 2024 | |
Business segment | ||||||
Risk | 10,800 | 11,100 | 11,000 | 10,400 | 10,900 | 11,000 |
Scientific, Technical & Medical | 9,500 | 9,500 | 9,700 | 9,300 | 9,600 | 9,600 |
Legal | 11,300 | 11,800 | 11,800 | 10,900 | 11,900 | 11,800 |
Exhibitions | 3,300 | 3,500 | 3,300 | 3,300 | 3,500 | 3,500 |
Sub-total | 34,900 | 35,900 | 35,800 | 33,900 | 35,900 | 35,900 |
Corporate/shared functions | 800 | 600 | 600 | 800 | 600 | 600 |
Total | 35,700 | 36,500 | 36,400 | 34,700 | 36,500 | 36,500 |
Geographical location | ||||||
North America | 14,900 | 14,900 | 14,700 | 14,500 | 15,000 | 14,900 |
Europe | 9,800 | 10,000 | 9,300 | 9,500 | 9,900 | 9,600 |
Rest of world | 11,000 | 11,600 | 12,400 | 10,700 | 11,600 | 12,000 |
Total | 35,700 | 36,500 | 36,400 | 34,700 | 36,500 | 36,500 |
2022 | 2023 | 2024 | |
GBPm | GBPm | GBPm | |
Defined benefit pension expense | 19 | 5 | 4 |
Defined contribution pension expense | 131 | 137 | 140 |
Total | 150 | 142 | 144 |
| 2022 | 2023 | 2024 | |||||||
UK | US | Total | UK | US | Total | UK | US | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Service cost | 16 | 3 | 19 | 2 | 3 | 5 | 1 | 3 | 4 |
Defined benefit pension expense | 16 | 3 | 19 | 2 | 3 | 5 | 1 | 3 | 4 |
Net interest on net defined benefit pension | |||||||||
balance | 4 | 1 | 5 | 1 | - | 1 | - | 1 | 1 |
Net defined benefit pension expense | 20 | 4 | 24 | 3 | 3 | 6 | 1 | 4 | 5 |
AS AT 31 DECEMBER | 2022 | 2023 | 2024 | |||
UK | US | UK | US | UK | US | |
Discount rate | 4.90 % | 5.35 % | 4.60 % | 5.05 % | 5.55 % | 5.55 % |
Inflation | 3.20 % | 2.50 % | 3.05 % | 2.50 % | 3.15 % | 2.50 % |
AS AT 31 DECEMBER 2022 | Male average life | Female average | ||
expectancy | life expectancy | |||
UK | US | UK | US | |
Member currently aged 60 years | 85 | 86 | 89 | 88 |
Member currently aged 45 years | 87 | 86 | 90 | 89 |
AS AT 31 DECEMBER 2023 | Male average life | Female average | ||
expectancy | life expectancy | |||
UK | US | UK | US | |
Member currently aged 60 years | 85 | 86 | 88 | 88 |
Member currently aged 45 years | 86 | 86 | 90 | 89 |
AS AT 31 DECEMBER 2024 | Male average life | Female average | ||
expectancy | life expectancy | |||
UK | US | UK | US | |
Member currently aged 60 years | 85 | 86 | 89 | 88 |
Member currently aged 45 years | 86 | 86 | 90 | 89 |
| 2023 | 2024 | |||||
UK | US | Total | UK | US | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Defined benefit obligation | ||||||
At start of year | (2,887) | (865) | (3,752) | (2,984) | (822) | (3,806) |
Service cost | (2) | (3) | (5) | (1) | (3) | (4) |
Interest on pension scheme liabilities | (138) | (43) | (181) | (133) | (40) | (173) |
Actuarial (losses)/gains on financial assumptions | (61) | (19) | (80) | 301 | 20 | 321 |
Actuarial (losses)/gains arising from experience | ||||||
assumptions | (16) | 5 | (11) | (20) | (3) | (23) |
Contributions by employees | (8) | - | (8) | (7) | - | (7) |
Benefits paid | 128 | 57 | 185 | 134 | 61 | 195 |
Exchange translation differences | - | 46 | 46 | - | (16) | (16) |
At end of yea r | (2,984) | (822) | (3,806) | (2,710) | (803) | (3,513) |
Fair value of scheme assets | ||||||
At start of yea r | 2,852 | 854 | 3,706 | 2,937 | 834 | 3,771 |
Interest income on plan assets | 137 | 43 | 180 | 133 | 39 | 172 |
Return on assets excluding amounts included in | ||||||
interest income | 1 | 34 | 35 | (240) | (33) | (273) |
Contributions by employer | 67 | 6 | 73 | 41 | 7 | 48 |
Contributions by employees | 8 | - | 8 | 7 | - | 7 |
Benefits paid | (128) | (57) | (185) | (134) | (61) | (195) |
Exchange translation differences | - | (46) | (46) | - | 14 | 14 |
At end of yea r | 2,937 | 834 | 3,771 | 2,744 | 800 | 3,544 |
Opening net balance | (35) | (11) | (46) | (47) | 12 | (35) |
Service cost | (2) | (3) | (5) | (1) | (3) | (4) |
Net interest on net defined benefit balance | (1) | - | (1) | - | (1) | (1) |
Contributions by employer | 67 | 6 | 73 | 41 | 7 | 48 |
Actuarial (losses)/gains | (76) | 20 | (56) | 41 | (16) | 25 |
Exchange translation differences | - | - | - | - | (2) | (2) |
Net pension balance | (47) | 12 | (35) | 34 | (3) | 31 |
Impact of asset ceiling | (6) | (22) | (28) | (4) | (6) | (10) |
Overall net pension balance | (53) | (10) | (63) | 30 | (9) | 21 |
2023 | 2024 | |
GBPm | GBPm | |
Net pension asset recognised | 119 | 186 |
Net pension obligation | (182) | (165) |
Overall net pension balance | (63) | 21 |
2022 | 2023 | 2024 | |
GBPm | GBPm | GBPm | |
Gains and losses arising during the year: | |||
Experience losses on scheme liabilities | (88) | (11) | (23) |
Experience (losses)/gains on scheme assets | (1,820) | 35 | (273) |
Actuarial gains/(losses) on the present value of scheme liabilities due to changes in: | |||
– discount rates | 2,000 | (145) | 374 |
– inflation | 32 | 15 | (36) |
– other actuarial assumptions | 1 | 50 | (17) |
125 | (56) | 25 |
FAIR VALUE OF SCHEME ASSETS | 2023 | 2024 | ||||
UK | US | Total | UK | US | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Equities ¹ | 431 | 3 | 434 | 419 | 2 | 421 |
Liability matching assets ² | 1,760 | 804 | 2,564 | 1,716 | 784 | 2,500 |
Property funds and ground leases ³ | 406 | - | 406 | 172 | - | 172 |
Direct lending and multi-asset credit funds | 229 | - | 229 | 333 | - | 333 |
Cash and cash equivalents ⁴ | 98 | 27 | 125 | 96 | 14 | 110 |
Othe r | 13 | - | 13 | 8 | - | 8 |
Total | 2,937 | 834 | 3,771 | 2,744 | 800 | 3,544 |
GBPm |
|
Increase/decrease of 0.5% in discount rate |
124 |
Increase/decrease of 0.25% in the expected inflation rate |
55 |
Increase/decrease of one year in assumed life expectancy |
55 |
2022 |
2023 |
2024 |
|
GBPm |
GBPm |
GBPm |
|
Interest on short-term bank loans, overdrafts and commercial paper |
(19) |
(31) |
(48) |
Interest on term debt |
(157) |
(263) |
(228) |
Interest on lease liabilities |
(6) |
(6) |
(5) |
Total borrowing costs |
(182) |
(300) |
(281) |
Losses on loans and derivatives not designated as hedges |
(9) |
(20) |
(20) |
Fair value losses on designated fair value hedge relationships |
(9) |
(2) |
(2) |
Net financing charge on defined benefit pension schemes |
(5) |
(1) |
(1) |
Finance costs |
(205) |
(323) |
(304) |
Interest on bank deposits |
4 |
8 |
6 |
Finance income |
4 |
8 |
6 |
Net finance costs |
(201) |
(315) |
(298) |
2022 |
2023 |
2024 |
|
GBPm |
GBPm |
GBPm |
|
Revaluation of investments |
9 |
(11) |
(2) |
Loss on disposal of businesses and assets held for sale |
(18) |
(61) |
(4) |
Net loss on disposals and othe r non-operating items |
(9) |
(72) |
(6) |
2022 |
2023 |
2024 |
|
GBPm |
GBPm |
GBPm |
|
Current tax |
|||
Current year |
(564) |
(652) |
(661) |
Prior years |
30 |
77 |
54 |
Total current tax charge |
(534) |
(575) |
(607) |
Deferred tax |
53 |
68 |
(6) |
Tax expense |
(481) |
(507) |
(613) |
2022 |
2023 |
2024 |
||||
GBPm |
% |
GBPm |
% |
GBPm |
% |
|
Profit before tax |
2,113 |
2,295 |
2,557 |
|||
Tax at average applicable rates |
(498) |
23.6 % |
(571) |
24.9 % |
(647) |
25.3 % |
Tax effect of share of results of joint ventures |
||||||
and associates |
3 |
(0.1)% |
8 |
(0.3)% |
9 |
(0.4)% |
Income not taxable and expenses not deductible |
21 |
(1.0)% |
20 |
(0.9)% |
16 |
(0.6)% |
Non-deductible costs of share based |
||||||
remuneration |
(1) |
0.0 % |
(1) |
0.0 % |
(2) |
0.1 % |
Non-deductible disposal-related gains and losses |
(2) |
0.1 % |
(22) |
1.0 % |
(7) |
0.3 % |
Deferred tax assets of the period not recognised |
(17) |
0.8 % |
(3) |
0.1 % |
(18) |
0.7 % |
Change in recognition and measurement of |
||||||
deferred tax |
5 |
(0.2)% |
4 |
(0.2)% |
13 |
(0.5)% |
Movements in provisions and prior year items |
8 |
(0.4)% |
58 |
(2.5)% |
23 |
(0.9)% |
Tax expense |
(481) |
22.8 % |
(507) |
22.1 % |
(613) |
24.0 % |
2022 |
2023 |
2024 |
|
GBPm |
GBPm |
GBPm |
|
Tax on items that will not be reclassified to profit or loss |
|||
Tax on actuarial movements on defined benefit pension schemes |
(43) |
19 |
(11) |
Tax on items that may be reclassified to profit or loss |
|||
Tax on fair value movements on cash flow hedges |
8 |
(12) |
3 |
Net tax (charge)/credit recognised in other comprehensive income |
(35) |
7 |
(8) |
Tax credit on share based remuneration recognised directly in equity |
- |
24 |
20 |
2023 |
2024 |
|
GBPm |
GBPm |
|
Current tax assets |
6 |
42 |
Current tax liabilities |
(163) |
(119) |
Total |
(157) |
(77) |
2023 |
2024 |
|
GBPm |
GBPm |
|
Deferred tax assets |
128 |
84 |
Deferred tax liabilities |
(473) |
(473) |
Total |
(345) |
(389) |
Deferred tax liabilities |
Deferred tax assets |
||||||
Acquired |
Other |
Acquired |
Losses and |
Other |
|||
intangible |
temporary |
intangible |
other tax |
Pension |
temporary |
||
assets |
differences |
assets |
attributes |
balances |
differences |
Total |
|
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
GBPm |
|
Deferred tax (liability)/asset at |
|||||||
1 January 2023 |
(735) |
(231) |
132 |
118 |
49 |
223 |
(444) |
Credit/(charge) to profit |
63 |
40 |
(31) |
(26) |
(1) |
23 |
68 |
(Charge)/credit to equity/other |
|||||||
comprehensive income |
- |
(2) |
- |
- |
(1) |
11 |
8 |
Acquisitions |
(16) |
1 |
- |
9 |
- |
- |
(6) |
Disposals and othe r |
3 |
- |
- |
- |
- |
- |
3 |
Exchange translation differences |
33 |
10 |
(2) |
(5) |
- |
(10) |
26 |
Deferred tax (liability)/asset at |
|||||||
1 January 2024 |
(652) |
(182) |
99 |
96 |
47 |
247 |
(345) |
Credit/(charge) to profit |
52 |
14 |
(31) |
(31) |
(10) |
- |
(6) |
(Charge)/credit to equity/other |
|||||||
comprehensive income |
- |
(14) |
- |
- |
6 |
1 |
(7) |
Acquisitions |
(16) |
- |
- |
1 |
- |
- |
(15) |
Disposals and othe r |
- |
- |
- |
- |
- |
(2) |
(2) |
Exchange translation differences |
(10) |
(1) |
(2) |
(2) |
- |
1 |
(14) |
Deferred tax (liability)/asset at |
|||||||
31 December 2024 |
(626) |
(183) |
66 |
64 |
43 |
247 |
(389) |
2023 |
2024 |
|||
GBPm |
GBPm |
GBPm |
GBPm |
|
Gross amount |
Tax effected |
Gross amount |
Tax effected |
|
Trading losses and temporary differences expiring |
||||
Within 10 years |
93 |
26 |
55 |
15 |
More than 10 years |
14 |
4 |
13 |
3 |
Available indefinitely |
246 |
66 |
185 |
51 |
Total |
353 |
96 |
253 |
69 |
State and local tax losses expiring |
||||
Within 10 years |
21 |
1 |
18 |
1 |
More than 10 years |
63 |
4 |
57 |
3 |
Available indefinitely |
- |
- |
- |
- |
Total |
84 |
5 |
75 |
4 |
Capital losses expiring |
||||
Within 10 years |
- |
- |
- |
- |
More than 10 years |
- |
- |
- |
- |
Available indefinitely |
27 |
7 |
140 |
31 |
Total |
27 |
7 |
140 |
31 |
EARNINGS PER SHARE – FOR THE | |||||||||
YEAR ENDED 31 DECEMBER | 2022 | 2023 | 2024 | ||||||
Weighted | Weighted | Weighted | |||||||
Net profit | average | Net profit | average | Net profit | average | ||||
attributable to | number | attributable to | number | attributable to | number | ||||
shareholders | of shares | EPS | shareholders | of shares | EPS | shareholders | of shares | EPS | |
GBPm | (millions) | (pence) | GBPm | (millions) | (pence) | GBPm | (millions) | (pence) | |
Basic earnings per share | 1,634 | 1,918.5 | 85.2p | 1,781 | 1,891.8 | 94.1p | 1,934 | 1,865.9 | 103.6p |
Diluted earnings per share | 1,634 | 1,929.3 | 84.7p | 1,781 | 1,902.8 | 93.6p | 1,934 | 1,876.7 | 103.1p |
2022 | 2023 | 2024 | |
RECONCILIATION OF OPERATING PROFIT TO CASH GENERATED FROM OPERATIONS | GBPm | GBPm | GBPm |
Operating profit | 2,323 | 2,682 | 2,861 |
Share of results of joint ventures and associates | (19) | (46) | (43) |
Amortisation of acquired intangible assets | 294 | 279 | 258 |
Amortisation of internally developed intangible assets | 309 | 330 | 364 |
Amortisation of pre-publication costs | 72 | 76 | 77 |
Depreciation of property, plant and equipment | 47 | 43 | 34 |
Depreciation of right-of-use assets | 63 | 65 | 50 |
Share based remuneration | 46 | 56 | 66 |
Total non-cash items | 831 | 849 | 849 |
Increase in inventories and pre-publication costs | (103) | (90) | (83) |
Increase in receivables | (251) | (24) | (173) |
Increase/(decrease) in payables | 280 | (1) | 110 |
Increase in working capital | (74) | (115) | (146) |
Cash generated from operations | 3,061 | 3,370 | 3,521 |
CASH FLOW ON ACQUISITIONS | 2022 | 2023 | 2024 | |
Note | GBPm | GBPm | GBPm | |
Purchase of businesses | 12 | (373) | (108) | (165) |
Deferred payments relating to prior year acquisitions | (21) | (16) | (5) | |
Total | (394) | (124) | (170) |
RECONCILIATION OF NET DEBT | Related | ||||
Cash and | derivative | Finance | |||
cash | financial | Lease | |||
equivalents | Debt | instruments | receivable | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | |
At 1 January 2023 | 334 | (6,730) | (213) | 5 | (6,604) |
Decrease in cash and cash equivalents | (169) | - | - | - | (169) |
Increase in short-term bank loans, overdrafts and | |||||
commercial paper | - | (84) | - | - | (84) |
Issuance of term debt | - | (651) | - | - | (651) |
Repayment of term debt | - | 847 | - | - | 847 |
Repayment of leases | - | 72 | - | (2) | 70 |
Change in net debt resulting from cash flows | (169) | 184 | - | (2) | 13 |
Borrowings in disposed businesses | - | 1 | - | - | 1 |
Inception of leases | - | (38) | - | 1 | (37) |
Fair value and other adjustments to debt and related | |||||
derivatives | - | (100) | 97 | - | (3) |
Exchange translation differences | (10) | 186 | 8 | - | 184 |
At 1 January 2024 | 155 | (6,497) | (108) | 4 | (6,446) |
Decrease in cash and cash equivalents | (32) | - | - | - | (32) |
Increase in short-term bank loans, overdrafts and | |||||
commercial paper | - | (461) | - | - | (461) |
Issuance of term debt | - | (711) | - | - | (711) |
Repayment of term debt | - | 1,017 | - | - | 1,017 |
Repayment of leases | - | 63 | - | (2) | 61 |
Change in net debt resulting from cash flows | (32) | (92) | - | (2) | (126) |
Borrowings in disposed businesses | - | 8 | - | - | 8 |
Remeasurement and derecognition of leases | - | (4) | - | - | (4) |
Inception of leases | - | (32) | - | - | (32) |
Fair value and other adjustments to debt and related | |||||
derivatives | - | 19 | (28) | - | (9) |
Exchange translation differences | (4) | 54 | (4) | - | 46 |
At 31 December 2024 | 119 | (6,544) | (140) | 2 | (6,563) |
Fair value | Fair value | Fair value | |
2022 | 2023 | 2024 | |
GBPm | GBPm | GBPm | |
Goodwill | 269 | 68 | 146 |
Intangible assets | 125 | 64 | 72 |
Property, plant and equipment | 1 | 1 | - |
Other non-current assets | 3 | - | - |
Current assets | 8 | 3 | 6 |
Current liabilities | (21) | (10) | (14) |
Borrowings | (3) | - | - |
Deferred tax | (13) | (6) | (15) |
Net assets acquired | 369 | 120 | 195 |
Consideration (after taking account of £7m net cash acquired (2022: £6m; | |||
2023: £4m)) | 369 | 120 | 195 |
Change in consideration deferred to future years and changes in contingent | |||
consideration relating to prior year acquisitions | 4 | (12) | (30) |
Net cash flow | 373 | 108 | 165 |
ORDINARY DIVIDENDS PAID IN THE YEAR | 2022 | 2023 | 2024 |
GBPm | GBPm | GBPm | |
RELX PLC | 983 | 1,059 | 1,121 |
■ | Market-related assets – 1 to 40 years |
■ | Customer-related assets – 1 to 20 years |
■ | Editorial content – 1 to 40 years |
■ | Software and systems – 1 to 10 years |
■ | Other – 3 to 20 years |
Total | Total | ||||||||
Total | internally | intangible | |||||||
Software | acquired | developed | assets | ||||||
Market | Customer | Editorial | and | intangible | intangible | excluding | |||
Goodwill | related | related | content | technology | Other | assets | assets | goodwill | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
COST | |||||||||
As at 1 January 2023 | 8,388 | 2,699 | 2,076 | 690 | 845 | 2,518 | 8,828 | 4,120 | 12,948 |
Acquisitions | 68 | 1 | 28 | 1 | 31 | 3 | 64 | - | 64 |
Additions | - | - | - | - | - | - | - | 447 | 447 |
Disposals and other ¹ | (51) | (28) | (29) | (11) | (4) | (9) | (81) | (59) | (140) |
Exchange translation differences | (382) | (132) | (96) | (22) | (37) | (86) | (373) | (165) | (538) |
At 1 January 2024 | 8,023 | 2,540 | 1,979 | 658 | 835 | 2,426 | 8,438 | 4,343 | 12,781 |
Acquisitions | 146 | 10 | 14 | 10 | 38 | - | 72 | - | 72 |
Additions | - | - | - | - | - | - | - | 464 | 464 |
Disposals and other ² | (36) | (71) | (8) | (6) | (23) | (110) | (218) | (87) | (305) |
Exchange translation differences | 83 | 36 | 25 | 4 | 5 | 7 | 77 | 2 | 79 |
At 31 December 2024 | 8,216 | 2,515 | 2,010 | 666 | 855 | 2,323 | 8,369 | 4,722 | 13,091 |
ACCUMULATED AMORTISATION | |||||||||
As at 1 January 2023 | - | 1,718 | 1,332 | 617 | 572 | 2,500 | 6,739 | 2,685 | 9,424 |
Charge for the year | - | 116 | 73 | 15 | 63 | 12 | 279 | 330 | 609 |
Disposals and other ¹ | - | (16) | (19) | (5) | (8) | (9) | (57) | (41) | (98) |
Exchange translation differences | - | (87) | (63) | (20) | (27) | (87) | (284) | (108) | (392) |
At 1 January 2024 | - | 1,731 | 1,323 | 607 | 600 | 2,416 | 6,677 | 2,866 | 9,543 |
Charge for the year | - | 111 | 71 | 13 | 62 | 1 | 258 | 364 | 622 |
Disposals and other ² | - | (69) | (8) | (5) | (23) | (110) | (215) | (71) | (286) |
Exchange translation differences | - | 23 | 15 | 3 | 6 | 7 | 54 | (6) | 48 |
At 31 December 2024 | - | 1,796 | 1,401 | 618 | 645 | 2,314 | 6,774 | 3,153 | 9,927 |
NET BOOK AMOUNT | |||||||||
At 31 December 2023 | 8,023 | 809 | 656 | 51 | 235 | 10 | 1,761 | 1,477 | 3,238 |
At 31 December 2024 | 8,216 | 719 | 609 | 48 | 210 | 9 | 1,595 | 1,569 | 3,164 |
GOODWILL | 2023 | 2024 |
GBPm | GBPm | |
Risk | 3,950 | 4,004 |
Scientific, Technical & Medical | 1,923 | 1,948 |
Legal | 1,524 | 1,640 |
Exhibitions | 626 | 624 |
Total | 8,023 | 8,216 |
KEY ASSUMPTIONS | 2023 | 2024 | ||
Nominal | Nominal | |||
Pre-tax | long-term | Pre-tax | long-term | |
discount | market | discount | market | |
rate | growth rate | rate | growth rate | |
Risk | 11.3% | 4% | 11.3% | 4% |
Scientific, Technical & Medical | 10.6% | 3% | 10.6% | 3% |
Legal | 10.9% | 4% | 10.9% | 4% |
Exhibitions | 12.3% | 4% | 12.3% | 4% |
2023 | 2024 | |
GBPm | GBPm | |
Investments in joint ventures and associates | 178 | 169 |
Venture capital and other investments | 97 | 92 |
Total | 275 | 261 |
2023 | 2024 | |
GBPm | GBPm | |
At start of yea r | 159 | 178 |
Share of results of joint ventures and associates | 46 | 43 |
Dividends received from joint ventures and associates | (21) | (37) |
Exchange translation differences | (6) | (15) |
At end of yea r | 178 | 169 |
RELX’s share | ||
2023 | 2024 | |
GBPm | GBPm | |
Revenue | 123 | 121 |
Net profit for the year | 46 | 43 |
Total assets | 200 | 198 |
Total liabilities | (61) | (97) |
Net assets | 139 | 101 |
Goodwill | 39 | 68 |
Total | 178 | 169 |
| 2023 | 2024 | |||||
Land and | Fixtures and | Land and | Fixtures and | |||
buildings | equipment | Total | buildings | equipment | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Cost | ||||||
At start of yea r | 166 | 452 | 618 | 134 | 373 | 507 |
Acquisitions | - | 1 | 1 | - | - | - |
Capital expenditure | 5 | 25 | 30 | 1 | 19 | 20 |
Disposals | (30) | (88) | (118) | (25) | (104) | (129) |
Exchange translation differences | (7) | (17) | (24) | - | - | - |
At end of year | 134 | 373 | 507 | 110 | 288 | 398 |
Accumulated depreciation | ||||||
At start of year | 115 | 377 | 492 | 92 | 316 | 408 |
Charge for the yea r | 5 | 38 | 43 | 5 | 29 | 34 |
Disposals | (23) | (85) | (108) | (23) | (103) | (126) |
Exchange translation differences | (5) | (14) | (19) | - | - | - |
At end of year | 92 | 316 | 408 | 74 | 242 | 316 |
Net book amount | 42 | 57 | 99 | 36 | 46 | 82 |
AT 31 DECEMBER 2023 | Contractual cash flow (including interest) | |||||||
Carrying | Within | More than | ||||||
amount | 1 year | 1-2 years | 2-3 years | 3-4 years | 4-5 years | 5 years | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Borrowings | ||||||||
Fixed rate borrowings | (6,136) | (1,174) | (762) | (764) | (538) | (792) | (3,037) | (7,067) |
Floating rate borrowings | (220) | (220) | - | - | - | - | - | (220) |
Lease liabilities | (141) | (66) | (45) | (17) | (12) | (6) | (28) | (174) |
(6,497) | ||||||||
Derivative financial liabilities | ||||||||
Cash inflows | 621 | 92 | 14 | 3 | - | - | 730 | |
Cash outflows | (632) | (94) | (14) | (3) | - | - | (743) | |
Forward foreign exchange contracts | (16) | (11) | (2) | - | - | - | - | (13) |
Interest rate derivatives | (104) | (35) | (17) | (13) | (13) | (14) | (27) | (119) |
Cross-currency interest rate swaps | (27) | (34) | (539) | - | - | - | - | (573) |
(147) | ||||||||
Derivative financial assets | ||||||||
Cash inflows | 1,149 | 364 | 199 | 30 | - | - | 1,742 | |
Cash outflows | (1,111) | (339) | (186) | (29) | - | - | (1,665) | |
Forward foreign exchange contracts | 62 | 38 | 25 | 13 | 1 | - | - | 77 |
Interest rate derivatives | 19 | - | 4 | 6 | 5 | 4 | 19 | 38 |
Cross-currency interest rate swaps | - | 7 | 527 | - | - | - | - | 534 |
81 | ||||||||
Total | (6,563) | (1,495) | (809) | (775) | (557) | (808) | (3,073) | (7,517) |
AT 31 DECEMBER 2024 | Contractual cash flow (including interest) | |||||||
Carrying | Within | More than | ||||||
amount | 1 year | 1-2 years | 2-3 years | 3-4 years | 4-5 years | 5 years | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Borrowings | ||||||||
Fixed rate borrowings | (5,679) | (763) | (756) | (541) | (783) | (862) | (2,979) | (6,684) |
Floating rate borrowings | (762) | (762) | - | - | - | - | - | (762) |
Lease liabilities | (103) | (43) | (28) | (19) | (10) | (4) | (27) | (131) |
(6,544) | ||||||||
Derivative financial liabilities | ||||||||
Cash inflows | 1,560 | 180 | 124 | 17 | - | - | 1,881 | |
Cash outflows | (1,575) | (184) | (126) | (17) | - | - | (1,902) | |
Forward foreign exchange contracts | (23) | (15) | (4) | (2) | - | - | - | (21) |
Interest rate derivatives | (119) | (25) | (22) | (22) | (22) | (22) | (22) | (135) |
Cross-currency interest rate swaps | (43) | (550) | - | - | - | - | - | (550) |
(185) | ||||||||
Derivative financial assets | ||||||||
Cash inflows | 827 | 274 | 85 | 6 | - | - | 1,192 | |
Cash outflows | (788) | (251) | (77) | (6) | - | - | (1,122) | |
Forward foreign exchange contracts | 53 | 39 | 23 | 8 | - | - | - | 70 |
Interest rate derivatives | 21 | 3 | 5 | 5 | 4 | 3 | 16 | 36 |
Cross-currency interest rate swaps | - | 502 | - | - | - | - | - | 502 |
74 | ||||||||
Total | (6,655) | (1,614) | (782) | (571) | (811) | (885) | (3,012) | (7,675) |
2022 | 2023 | 2024 | |
GBPm | GBPm | GBPm | |
Up to one month | 265 | 259 | 217 |
2 to 3 months | 115 | 130 | 130 |
4 to 6 months | 46 | 56 | 57 |
Greater than 6 months | 23 | 35 | 24 |
Total past due | 449 | 480 | 428 |
FAIR VALUE HEDGE RELATIONSHIPS | 31 December | 31 December | ||
2023 | 2024 | |||
Principal | Principal | |||
amount | amount | |||
GBPm | GBPm | Fixed rate | Floating rate | |
€500m bond and €500m interest rate swaps maturing 2024 | (433) | - | 1.0% | Euribor+0.7% |
€600m bond and €600m/$669.3m cross-currency interest rate | ||||
| swaps maturing 2025 | (524) | (535) | 1.3% | USD SOFR+1.5% |
$750m bond and $750m interest rate swaps maturing 2030 | (588) | (599) | 3.0% | USD SOFR+1.8% |
€750m bond and €750m interest rate swaps maturing 2031 | (650) | (620) | 3.8% | Euribor+0.9% |
$500m bond and $500m interest rate swaps maturing 2032 | (392) | (399) | 4.8% | USD SOFR+2.0% |
(2,587) | (2,153) |
GAINS/(LOSSES) ON BORROWINGS AND RELATED DERIVATIVES AND | Fair value | ||||
CARRYING VALUES | 1 January | movement | Exchange | 31 December | Carrying |
2022 | gain/(loss) | gain/(loss) | 2022 | values | |
GBPm | GBPm | GBPm | GBPm | GBPm | |
USD debt | (1) | 140 | 2 | 141 | (1,630) |
Related interest rate swaps | 8 | (149) | (2) | (143) | (143) |
7 | (9) | - | (2) | (1,773) | |
EUR debt | (27) | 96 | 1 | 70 | (924) |
Related interest rate swaps | 27 | (96) | (1) | (70) | (70) |
- | - | - | - | (994) | |
Total relating to USD and EUR debt | (28) | 236 | 3 | 211 | (2,554) |
Total related interest rate swaps | 35 | (245) | (3) | (213) | (213) |
Net gain on borrowings and related | |||||
derivatives/total carrying value | 7 | (9) | - | (2) | (2,767) |
GAINS/(LOSSES) ON BORROWINGS AND RELATED DERIVATIVES | Fair value | |||||
AND CARRYING VALUES | 1 January | movement | Redemption/ | Exchange | 31 December | Carrying |
2023 | gain/(loss) | close-out | gain/(loss) | 2023 | values | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
USD debt | 141 | (22) | (16) | (6) | 97 | (871) |
Related interest rate swaps | (143) | 21 | 16 | 6 | (100) | (100) |
(2) | (1) | - | - | (3) | (971) | |
EUR debt | 70 | (61) | - | (2) | 7 | (1,600) |
Related interest rate swaps | (70) | 60 | - | 2 | (8) | (8) |
- | (1) | - | - | (1) | (1,608) | |
Total relating to USD and EUR debt | 211 | (83) | (16) | (8) | 104 | (2,471) |
Total related interest rate swaps | (213) | 81 | 16 | 8 | (108) | (108) |
Net gain/(loss) on borrowings and related | ||||||
derivatives/total carrying value | (2) | (2) | - | - | (4) | (2,579) |
GAINS/(LOSSES) ON BORROWINGS AND RELATED DERIVATIVES | Fair value | 31 | ||||
AND CARRYING VALUES | 1 January | movement | Redemption/ | Exchange | December | Carrying |
2024 | gain/(loss) | close-out | gain/(loss) | 2024 | values | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
USD debt | 97 | 14 | - | 3 | 114 | (875) |
Related interest rate swaps | (100) | (16) | - | (3) | (119) | (119) |
(3) | (2) | - | - | (5) | (994) | |
EUR debt | 7 | 12 | - | 1 | 20 | (1,133) |
Related interest rate swaps | (8) | (12) | - | (1) | (21) | (21) |
(1) | - | - | - | (1) | (1,154) | |
Total relating to USD and EUR debt | 104 | 26 | - | 4 | 134 | (2,008) |
Total related interest rate swaps | (108) | (28) | - | (4) | (140) | (140) |
Net loss on borrowings and related | ||||||
derivatives/total carrying value | (4) | (2) | - | - | (6) | (2,148) |
Cost of | Foreign | |||
Interest rate | hedging | currency | ||
hedge reserve | reserve | hedge reserve | Total | |
GBPm | GBPm | GBPm | GBPm | |
Hedge reserve at 31 December 2022: losses deferred | (2) | (1) | (8) | (11) |
Gains/(losses) arising in 2023 | 1 | (3) | 31 | 29 |
Amounts recognised in income statement | 1 | - | 17 | 18 |
Hedge reserve at 31 December 2023: (losses)/gains deferred | - | (4) | 40 | 36 |
(Losses)/gains arising in 2024 | (5) | 6 | 10 | 11 |
Amounts recognised in income statement | 2 | - | (22) | (20) |
Hedge reserve at 31 December 2024: (losses)/gains deferred | (3) | 2 | 28 | 27 |
Foreign | Principal | ||
currency | amount of | Carrying | |
hedge reserve | hedges | values | |
GBPm | GBPm | GBPm | |
2025 | 17 | 465 | 25 |
2026 | 11 | 501 | 11 |
2027 | - | 268 | - |
2028 | - | 30 | - |
Total | 28 | 1,264 | 36 |
2023 | 2024 | |
GBPm | GBPm | |
Raw materials | 1 | - |
Pre-publication costs | 278 | 302 |
Finished goods | 39 | 29 |
Total | 318 | 331 |
2023 | 2024 | |
GBPm | GBPm | |
Trade receivables | 2,144 | 2,306 |
Loss allowance | (119) | (122) |
2,025 | 2,184 | |
Prepayments and accrued income | 288 | 283 |
Current tax receivable | 6 | 42 |
Net finance lease receivable | 4 | 2 |
Total | 2,323 | 2,511 |
2023 | 2024 | |
GBPm | GBPm | |
At start of yea r | 118 | 119 |
Charge for the year | 8 | 17 |
Trade receivables written off | (3) | (13) |
Exchange translation differences | (4) | (1) |
At end of yea r | 119 | 122 |
2023 | 2024 | |
GBPm | GBPm | |
Trade payables | 171 | 223 |
Accruals | 842 | 851 |
Social security and other taxes | 174 | 181 |
Other payables | 487 | 539 |
Deferred income | 2,297 | 2,328 |
Total | 3,971 | 4,122 |
2023 | 2024 | |||||
Falling due | Falling due | Falling due | Falling due | |||
within | in more than | within | in more than | |||
1 year | 1 year | Total | 1 year | 1 year | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Financial liabilities measured at amortised cost: | ||||||
Short-term bank loans, overdrafts and commercial paper | 220 | - | 220 | 762 | - | 762 |
Term debt | 606 | 2,940 | 3,546 | - | 3,551 | 3,551 |
Lease liabilities | 57 | 84 | 141 | 38 | 65 | 103 |
Term debt in fair value hedging relationships | 430 | 2,041 | 2,471 | 492 | 1,516 | 2,008 |
Term debt previously in fair value hedging relationships | - | 119 | 119 | 120 | - | 120 |
Total | 1,313 | 5,184 | 6,497 | 1,412 | 5,132 | 6,544 |
| 2023 | 2024 | |||||||
Short-term | Short-term | |||||||
bank loans, | bank loans, | |||||||
overdrafts | overdrafts | |||||||
and | and | |||||||
commercial | Lease | commercial | Lease | |||||
paper | Term debt | liabilities | Total | paper | Term debt | liabilities | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
Within 1 year | 220 | 1,036 | 57 | 1,313 | 762 | 612 | 38 | 1,412 |
Within 1 to 2 years | - | 620 | 19 | 639 | - | 619 | 13 | 632 |
Within 2 to 3 years | - | 647 | 18 | 665 | - | 412 | 12 | 424 |
Within 3 to 4 years | - | 432 | 17 | 449 | - | 658 | 12 | 670 |
Within 4 to 5 years | - | 689 | 9 | 698 | - | 753 | 9 | 762 |
After 5 years | - | 2,712 | 21 | 2,733 | - | 2,625 | 19 | 2,644 |
After 1 yea r | - | 5,100 | 84 | 5,184 | - | 5,067 | 65 | 5,132 |
Total | 220 | 6,136 | 141 | 6,497 | 762 | 5,679 | 103 | 6,544 |
| 2023 | 2024 | |||||||
Short-term | Short-term | |||||||
bank loans, | bank loans, | |||||||
overdrafts | overdrafts | |||||||
and | and | |||||||
commercial | Lease | commercial | Lease | |||||
paper | Term debt | liabilities | Total | paper | Term debt | liabilities | Total | |
GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | GBPm | |
US dolla r | 188 | 2,234 | 37 | 2,459 | 446 | 2,246 | 21 | 2,713 |
Pound sterling | - | - | 29 | 29 | 8 | - | 30 | 38 |
Euro | 24 | 3,902 | 47 | 3,973 | 295 | 3,433 | 29 | 3,757 |
Other currencies | 8 | - | 28 | 36 | 13 | - | 23 | 36 |
Total | 220 | 6,136 | 141 | 6,497 | 762 | 5,679 | 103 | 6,544 |
2023 | 2024 | |
GBPm | GBPm | |
At start of yea r | 145 | 113 |
Additions | 38 | 32 |
Remeasurement | 6 | 5 |
Disposals | (7) | (9) |
Depreciation | (65) | (50) |
Exchange translation differences | (4) | (2) |
At end of year | 113 | 89 |
2023 | 2024 | |
GBPm | GBPm | |
Current | ||
Property | (55) | (37) |
Non-property | (2) | (1) |
Non-current | ||
Property | (82) | (63) |
Non-property | (2) | (2) |
Total | (141) | (103) |
CALLED UP SHARE CAPITAL – ORDINARY SHARES OF UK 14 ⁵¹/₁₁₆ PENCE EACH | 2023 | 2024 | ||
ALLOTTED, ISSUED AND FULLY PAID | No. of shares | GBPm | No. of shares | GBPm |
At start of year | 1,934,880,088 | 279 | 1,906,907,605 | 275 |
Issue of ordinary shares | 3,027,517 | - | 2,937,114 | - |
Cancellation of ordinary shares | (31,000,000) | (4) | (29,000,000) | (3) |
At end of yea r | 1,906,907,605 | 275 | 1,880,844,719 | 272 |
NUMBER OF ORDINARY SHARES | Year ended 31 December | |||
2023 | 2024 | |||
Shares in | Shares in | |||
issue net of | issue net of | |||
treasury | Shares in | Treasury | treasury | |
shares* | issue | shares | shares* | |
(millions) | (millions) | (millions) | (millions) | |
At start of yea r | 1,909.5 | 1,906.9 | (25.4) | 1,881.5 |
Issue of ordinary shares | 3.0 | 2.9 | - | 2.9 |
Repurchase of ordinary shares | (30.9) | - | (28.9) | (28.9) |
Net (purchase)/release of shares by the Employee Benefit Trust | (0.1) | - | 0.4 | 0.4 |
Cancellation of ordinary shares | - | (29.0) | 29.0 | - |
At end of year | 1,881.5 | 1,880.8 | (24.9) | 1,855.9 |
Translation | Hedge | Other | |||
Total | reserve | reserve | reserves | Total | |
2023 | 2024 | 2024 | 2024 | 2024 | |
GBPm | GBPm | GBPm | GBPm | GBPm | |
At start of yea r | 2,394 | 392 | 27 | 1,761 | 2,180 |
Profit attributable to shareholders | 1,781 | - | - | 1,934 | 1,934 |
Dividends paid | (1,059) | - | - | (1,121) | (1,121) |
Actuarial (losses)/gains on defined benefit pension schemes | (75) | - | - | 43 | 43 |
Fair value movements on cash flow hedges | 29 | - | 11 | - | 11 |
Transfer to profit from cash flow hedge reserve | 18 | - | (20) | - | (20) |
Tax recognised in other comprehensive income | 7 | - | 3 | (11) | (8) |
Exchange differences on translation of foreign operations | (285) | 175 | - | - | 175 |
Cancellation of shares | (673) | - | - | (850) | (850) |
Increase in share based remuneration reserve (including tax) | 77 | - | - | 79 | 79 |
Settlement of share awards | (34) | - | - | (53) | (53) |
Acquisition of non ‐ controlling interests | - | - | - | (44) | (44) |
At end of yea r | 2,180 | 567 | 21 | 1,738 | 2,326 |
KEY MANAGEMENT PERSONNEL REMUNERATION | 2022 | 2023 | 2024 |
GBPm | GBPm | GBPm | |
Salaries, other short-term employee benefits and non-executive fees | 7 | 8 | 8 |
Share based remuneration* | 7 | 14 | 14 |
Total | 14 | 22 | 22 |
EXECUTIVE DIRECTORS | Annual | Share based | |||||
Salary | Benefits | incentive | remuneration* | Pension* | Total | ||
GBP’000 | GBP’000 | GBP’000 | GBP’000 | GBP’000 | GBP’000 | ||
Total Executive Directors | 2022 | 2,137 | 97 | 3,251 | 6,857 | 268 | 12,610 |
2023 | 2,190 | 97 | 3,808 | 14,354 | 241 | 20,690 | |
2024 | 2,245 | 109 | 3,576 | 14,322 | 247 | 20,499 |
2022 | 2023 | 2024 | |
NON-EXECUTIVE DIRECTORS | GBP’000 | GBP’000 | GBP’000 |
Fees and benefits | 1,566 | 1,566 | 1,781 |
Statement of | |||||
| Income statement | financial position | ||||
2022 | 2023 | 2024 | 2023 | 2024 | |
Euro to sterling | 1.17 | 1.15 | 1.18 | 1.15 | 1.21 |
US dollar to sterling | 1.24 | 1.24 | 1.28 | 1.28 | 1.25 |
Share | Reg | |
Company name | class | office |
Australia | ||
LNRS Data Services (Australia) Pty Ltd | Ordinary | AUS1 |
Reed Exhibitions Australia Pty Limited | Ordinary | AUS2 |
RELX Holdings Australia Pty Ltd | Ordinary | AUS2 |
RELX Trading Australia Pty Limited | Ordinary | AUS2 |
Austria | ||
LexisNexis Verlag ARD ORAC GmbH & Co KG | Partnership Interest | AUT2 |
ORAC GmbH | Ordinary | AUT2 |
RELX Austria GmbH | Ordinary | AUT3 |
RX CEE GmbH | Ordinary | AUT1 |
RX Salzburg GmbH | Ordinary | AUT3 |
Seminar Oberlaa GmbH | Ordinary | AUT4 |
Belgium | ||
LexisNexis BV | Ordinary | BEL1 |
Henchman B.V. | Ordinary | BEL2 |
Brazil | ||
Elsevier Editora Limiteda | Quotas | BRA1 |
Gestora de Inteligencia de Credito S.A. (20%) | Preferred, Ordinary | BRA6 |
LexisNexis Informacoes e Sistemas Empresariais Limiteda | Quotas | BRA4 |
LexisNexis Servicos de Analise de Risco Limiteda | Quotas | BRA5 |
MLex Brasil Midia Mercadologica Limiteda | Quotas | BRA3 |
Reed Exhibitions Alcantara Machado Limiteda | Quotas | BRA2 |
Canada | ||
Corps Events IntCan | Class A Voting | CAN3 |
Elsevier Canada Inc. | Class A Common | CAN2 |
Human API Technologies Inc. | Voting | CAN4 |
LexisNexis Canada Inc. | Class B Voting | CAN1 |
PCLaw Time Matters Canada Inc. | Common | CAN5 |
China | ||
Bakery China Exhibitions Co., Limited (25%) | Ordinary | CHN1 |
Beijing Medtime Elsevier Education Technology Co., Limited | Common | CHN2 |
(49%) | ||
Beijing Reed Elsevier Science and Technology Co Ltd 1 | Common | CHN19 |
C-One Energy (Guangzhou) Co., Limited | Ordinary | CHN5 |
Jingxunlingsi (Beijing) Information Technology Co Ltd 1 | Ordinary | CHN4 |
KeAi Communications Co., Limited (49%) | Ordinary | CHN15 |
LexisNexis Information Technology Co. Limited | Ordinary | CHN4 |
LexisNexis Risk Solutions (Shanghai) Information | Common | CHN7 |
Technologies Co Limited | ||
LNRS Data Services (Shanghai) Co Limited | Ordinary | CHN13 |
Peili Computer Co Ltd 1 | Ordinary | CHN13 |
Reed Elsevier Information Technology (Beijing) Co Limited | Common | CHN3 |
Reed Exhibitions (China) Co., Limited | Ordinary | CHN4 |
Reed Exhibitions Hengjin Co., Limited (51%) | Ordinary | CHN12 |
Reed Exhibitions Kuozhan (Shanghai) Co., Limited (60%) | Ordinary | CHN8 |
Reed Huabai Exhibitions (Beijing) Co., Limited (51%) | Ordinary | CHN4 |
RX Huabo Exhibitions (Shenzhen) Co., Limited (65%) | Ordinary | CHN16 |
Reed Huaqun Exhibitions Co., Limited (52%) | Ordinary | CHN4 |
Reed Sinopharm Exhibitions Co., Limited (50%) | Ordinary | CHN4 |
RX (China) Investment Co., Limited | Ordinary | CHN9 |
RX (Shenzhen) Co., Limited | Ordinary | CHN6 |
RX Huabo (Shenzhen) Technology Co. Limited 1 | Ordinary | CHN16 |
RX Technology (Shanghai) Co. Limited 1 | Ordinary | CHN18 |
Shanghai Datong Medical Information Technology Co., | Ordinary | CHN17 |
Limited | ||
Shanghai SinoReal Exhibitions Co., Limited (27.5%) | Ordinary | CHN11 |
Tianjin Beikeqilong Exhibition Services Limited (12.5%) | Ordinary | CHN10 |
Z&R Exhibitions Co., Limited (27.5%) | Ordinary | CHN14 |
Colombia | ||
LexisNexis Risk Solutions SAS | Ordinary | COL1 |
Denmark | ||
Elsevier A/S | Ordinary | DNK1 |
Egypt | ||
Elsevier Egypt LLC | Ordinary | EGY1 |
Share | Reg | |
Company name | class | office |
France | ||
Elsevier Holding France SAS | Ordinary | FRA1 |
Elsevier Masson SAS | Ordinary | FRA1 |
Fircosoft SAS | Ordinary | FRA6 |
GIE EDI Data (83%) | Ordinary | FRA2 |
GIE Juris Data | Ordinary | FRA2 |
LexisNexis Business Information Solutions SA | Ordinary | FRA2 |
LexisNexis Business Information Solutions Holding SA | Ordinary | FRA4 |
LexisNexis SA | Ordinary | FRA2 |
Reed Exhibitions ISG SARL | Ordinary | FRA3 |
RELX France SAS | Ordinary | FRA3 |
RELX France Services SAS | Ordinary | FRA6 |
RX France SAS | Ordinary | FRA3 |
SAFI Salon Français et Internationaux (50%) | Ordinary | FRA5 |
Germany | ||
Elsevier GmbH | Ordinary | DEU2 |
IPlytics GmbH | Ordinary | DEU6 |
LexisNexis GmbH | Ordinary | DEU3 |
PatentSight GmbH | Ordinary | DEU5 |
RELX Deutschland GmbH | Ordinary | DEU1 |
RX Deutschland GmbH | Ordinary | DEU7 |
Tschach Solutions GmbH | Ordinary | DEU4 |
Hong Kong | ||
Ascend China Holding Limited (deregistration in progress) | Ordinary | HNK4 |
JC Exhibition and Promotion Limited (65%) | Ordinary | HNK4 |
JYLN Sager Limited | Ordinary | HNK2 |
LNRS Data Services (China) Limited | Ordinary | HNK1 |
Reed Exhibitions Limited | Ordinary | HNK4 |
RELX (Greater China) Limited | Ordinary | HNK3 |
India | ||
FircoSoft India Private Limited (liquidation in progress) | Ordinary | IND2 |
Reed Elsevier Publishing (India) Private Limited | Ordinary | IND1 |
Reed Manch Exhibitions Private Limited | Ordinary | IND1 |
Reed Triune Exhibitions Private Limited | Ordinary | IND1 |
RELX India Private Limited | Ordinary | IND1 |
Indonesia | ||
PT Reed Exhibitions Indonesia (70%) | Series A, Series B | IDN1 |
PT RELX Information Analytics Indonesia | Common | IDN2 |
Irish Republic | ||
Elsevier (Ireland) Limited | Ordinary | IRL2 |
LexisNexis Risk Solutions (Europe) Limited | Ordinary | IRL1 |
RELX International Finance Designated Activity Company | Ordinary | IRL1 |
Israel | ||
LexisNexis Israel Ltd | Ordinary | ISR1 |
Italy | ||
Elsevier SRL | Registered Capital | ITA1 |
ICIS Italia SRL | Ordinary | ITA2 |
RX Italy SRL | Ordinary | ITA1 |
Japan | ||
Elsevier Japan KK | Ordinary | JPN1 |
LexisNexis Japan KK | Ordinary | JPN2 |
RX Japan Ltd | Ordinary | JPN2 |
Kingdom of Saudi Arabia | ||
RX Arabia LLC | Ordinary | KSA1 |
Korea (Republic of) | ||
Elsevier Korea LLC | Ordinary | KOR1 |
LexisNexis Legal and Professional Service Korea Limited | Ordinary | KOR1 |
Reed Exhibitions Korea Limited | Ordinary | KOR2 |
Reed Exporum Limited (60%) | Ordinary | KOR3 |
Reed K. Fairs Limited (70%) | Ordinary | KOR4 |
Share | Reg | |
Company name | class | office |
Macau | ||
Reed Exhibitions Macau Limited | Ordinary | MAC1 |
Malaysia | ||
LexisNexis Malaysia Sdn Bhd | Ordinary | MYS1 |
Mexico | ||
Human API Technologies, S. de R.L. de C.V. | Fixed | MEX2 |
Masson-Doyma Mexico, S.A. | Ordinary | MEX1 |
Reed Exhibitions Mexico S.A. de C.V. | Fixed | MEX1 |
Netherlands | ||
AGRM Solutions C.V. | Partnership Interest | NLD1 |
Caselex B.V. | Ordinary | NLD1 |
Elsevier B.V. | Ordinary | NLD1 |
ICIS Benchmarking Europe B.V. | Ordinary | NLD1 |
LexisNexis Business Information Solutions B.V. | Ordinary | NLD1 |
LNRS Data Services B.V. | Ordinary | NLD1 |
Misset Uitgeverij B.V. (49%) | Ordinary | NLD2 |
RELX Employment Company B.V. | Ordinary | NLD1 |
RELX Finance B.V. | Ordinary | NLD1 |
RELX Holdings B.V. | Ordinary | NLD1 |
RELX Nederland B.V. | Ordinary | NLD1 |
RELX Overseas B.V. | Ordinary RE | NLD1 |
New Zealand | ||
LexisNexis NZ Limited | Ordinary | NZL1 |
Philippines | ||
Reed Elsevier Shared Services (Philippines) Inc. | Common | PHL1 |
Poland | ||
AI Digital Contracts Sp. z.o.o. | Ordinary | POL1 |
Elsevier Sp. z.o.o. | Ordinary | POL2 |
Singapore | ||
Elsevier (Singapore) Pte Limited | Ordinary | SGP1 |
LNRS Data Services Pte Limited | Ordinary | SGP1 |
RE (HAPL) Pte Limited | Ordinary | SGP1 |
RELX (Singapore) Pte Limited | Ordinary | SGP2 |
South Africa | ||
LexisNexis (Pty) Limited (78%) | Ordinary | ZAF1 |
LexisNexis Risk Management (Pty) Limited (78%) | Ordinary | ZAF1 |
LexisNexis South Africa Shared Services (Pty) Limited | Ordinary | ZAF1 |
Reed Events Management (Pty) Limited (90%) | Ordinary | ZAF1 |
Reed Exhibitions (Pty) Limited (90%) | Ordinary | ZAF1 |
Reed Exhibitions Group (Pty) Limited (90%) | Ordinary | ZAF1 |
Reed Venue Management (Pty) Limited (90%) | Ordinary | ZAF1 |
RELX (Pty) Limited | Ordinary | ZAF1 |
Spain | ||
Elsevier Espana S.L.U | Participations | ESP1 |
Sweden | ||
Behaviometrics AB | A, B, and C shares | SWE1 |
Taiwan | ||
Elsevier Taiwan LLC | Ordinary | TWN1 |
Thailand | ||
Reed Tradex Company Limited (49%) | Ordinary | THA1 |
RELX Holding (Thailand) Co., Limited | Ordinary | THA2 |
RELX Information Analytics (Thailand) Co., Limited | Ordinary | THA3 |
Turkey | ||
Elsevier STM Bilgi Hizmetleri Limited Sirketi | Ordinary | TUR1 |
Reed Tuyap Fuarcilik A.S. (50%) | A Ordinary, B Ordinary | TUR2 |
United Arab Emirates | ||
Reed Exhibitions FZ-LLC | Ordinary | UAE1 |
RELX Middle East FZ-LLC | Ordinary | UAE2 |
Company name | class | office |
United Kingdom | ||
Aistemos Limited | Ordinary | GBR3 |
Butterworths Limited | Ordinary | GBR3 |
Cordery Compliance Limited (71%) | Ordinary | GBR3 |
Cordery Limited (71%) (in dissolution) | Ordinary | GBR3 |
Crediva Limited | Ordinary | GBR4 |
Elsevier Limited | Ordinary | GBR5 |
Interfolio UK Limited (in dissolution) | Ordinary | GBR6 |
LexisNexis Risk Solutions UK Limited | Ordinary | GBR4 |
LNRS Data Services Holdings Limited | Ordinary | GBR1 |
LNRS Data Services Limited | Ordinary | GBR1 |
Mack-Brooks Exhibitions Limited | Ordinary | GBR2 |
MLex Limited | Ordinary | GBR3 |
Offshore Europe (Management) Limited | Ordinary | GBR2 |
Offshore Europe Partnership (50%) | Partnership Interest GBR2 | |
RE (HPL) Limited | Ordinary | GBR1 |
RE (RCB) Limited | Ordinary | GBR1 |
RE Secretaries Limited | Ordinary | GBR1 |
RE (SOE) Limited | Ordinary | GBR2 |
Reed Events Limited | Ordinary | GBR2 |
Reed Exhibitions Limited | Ordinary | GBR2 |
RELX Finance Limited | Ordinary | GBR1 |
RELX Group plc 2 | Ordinary | GBR1 |
RELX (Holdings) Limited | Ordinary | GBR1 |
RELX (Investments) plc | Ordinary | GBR1 |
Reed Nominees Limited (in dissolution) | Ordinary | GBR1 |
RELX Overseas Holdings Limited | Ordinary | GBR1 |
RELX (UK) Limited | Ordinary | GBR1 |
REV GP (UK) LLP (50%) | Membership Interest GBR1 | |
REV Venture Partners Limited | Ordinary | GBR1 |
REV V LP | Partnership Interest GBR1 | |
SciBite Limited | Ordinary | GBR6 |
Sustainable Energy Conferences Limited | Ordinary | GBR3 |
Tracesmart Limited | Ordinary | GBR4 |
United States | ||
Accuity Asset Verification Services Inc. | Common Stock | USA1 |
American Textile Machinery Exhibition-International, | Common Stock | USA2 |
Inc. (40%) | ||
Aries Systems Corporation | Common Stock | USA2 |
Dunlap-Hanna Publishers (50%) | Partnership Interest | USA2 |
Elsevier Holdings Inc. | Common Stock | USA3 |
Elsevier Inc. | Common Stock | USA2 |
Elsevier STM Inc. | Common Stock | USA3 |
Enclarity, Inc. | Common Stock | USA1 |
Gaming Business Asia, LLC (50%) | Membership Interest USA2 | |
Health Market Science, Inc. | Common Stock | USA1 |
HumanAPI Inc. | Common Stock | USA1 |
ID Analytics, LLC | Membership Interest USA1 | |
Jarvis Software LLC | Membership Interest USA2 | |
Knovel Corporation | Common Stock | USA2 |
Knowable Inc | Common Stock | USA2 |
Legal InQuery Solutions Inc. | Common Stock | USA5 |
LexisNexis Claims Solutions Inc. | Common Stock | USA1 |
LexisNexis Coplogic Solutions Inc. | Common Stock | USA1 |
LexisNexis of Puerto Rico, Inc. | Common Stock | USA7 |
LexisNexis Risk Data Management, LLC | Membership Interest USA1 | |
LexisNexis Risk Holdings Inc. | Common Stock | USA1 |
LexisNexis Risk Solutions Inc. | Common Stock | USA1 |
LexisNexis Risk Solutions FL Inc. | Common Stock | USA1 |
LexisNexis Special Services Inc. | Common Stock | USA4 |
LexisNexis VitalChek Network Inc. | Common Stock | USA1 |
LNRS Data Services Inc. | Common Stock | USA1 |
Matthew Bender & Company, Inc. | Common Stock | USA2 |
MLex US, Inc. | Common Stock | USA2 |
PCLaw Time Matters LLC (51%) | Membership Interest USA8 | |
Portfolio Media, Inc. | Common Stock | USA2 |
Reed Technology and Information Services LLC | Membership Interest USA2 | |
RELX Capital Inc. | Common Stock | USA3 |
RELX Inc. | Common Stock | USA2 |
RELX Risks Inc. | Common Stock | USA6 |
Share | Reg | |
Company name | class | office |
United States | ||
REV IV Partnership LP | Partnership Interest | USA3 |
SAFI Americas LLC (50%) | Membership Interest USA2 | |
SageStream, LLC | Membership Interest USA1 | |
The Reed Elsevier Ventures 2011 Partnership LP | Partnership Interest | USA3 |
The Reed Elsevier Ventures 2013 Partnership LP | Partnership Interest | USA3 |
The Remick Publishers (50%) | Partnership Interest | USA2 |
ThreatMetrix, Inc. | Common Stock | USA1 |
World Compliance, Inc. | Common Stock | USA1 |
Vietnam | ||
Reed Tradex Vietnam LLC | Ordinary | VIE1 |
Registered offices | |
Australia | |
AUS1: | Building B, Level 2, Unit 11, 1 Maitland Place, Baulkham Hills, NSW 2153 |
AUS2: | Tower 2, Level 1, 475 Victoria Avenue, Chatswood NSW 2067 |
Austria | |
AUT1: | Messeplatz 1, 1020, Vienna |
AUT2: | Trabrennstrasse 2A,1020, Vienna |
AUT3: | Am Messezentrum 6, 5021, Salzburg |
AUT4: | Nikolaus-Pytty-Gasse 9, 1140 Wien |
Belgium | |
BEL1: | Oudenaardseheerweg 129, 9810 Nazareth |
BEL2: | Moutstraat 64, bus 502, 9000 Ghent, Belgium |
Brazil | |
BRA1: | Av. Almirante Barroso 81, Sala 33A114, 20031-004 Centro, Rio de Janeiro |
BRA2: | Rua Bela Cintra no. 1200, 10th floor, Sao Paulo, 01415-002 |
BRA3: | Avenida Paulista 2300, Andar Pilotis, Sao Paulo, SP 01 310-300 |
BRA4: | Rua Funchal, 538, 4º Andar, Conj. 42, Salas 4, 5 e 6, Vila Olímpia, Sao Paulo, |
04551-060 | |
BRA5: | Alameda Rio Negro, 161 Alphaville Industrial, Barueri, Sao Paulo 06.454-000 |
BRA6: | Alameda Araguaia, Alphaville, Conjuntos 81-84, Centro Empresarial |
Araguaia, Barueri, Sao Paulo | |
2104, 8-9 Andar | |
Canada | |
CAN1: | 111 Gordon Baker Road, Suite 900, Toronto, Ontario, M2H 3R1 |
CAN2: | 26E-1501 av. McGill College, Montreal, Quebec, H3A 3N9 |
CAN3: | 555 Richmond Street West, Suite 405, Toronto ON M5V 3B1 |
CAN4: | 20th Floor, 250 Howe Street, Vancouver BC, V6C 3R8 |
CAN5: | 199 Bay Street, 4000, Toronto, Ontario, M5L 1A9 |
China | |
CHN1: | Zhongkun Building, Room 612, Gaoliangqiaoxie Street, No. 59, Haidan |
District, Beijing, 100044 | |
CHN2: | Room 516, 5th Floor, Building 22, Area 11, No. 38, Xueyuan Road, Haidian |
District, Beijing, 100191 | |
CHN3: | Oriental Plaza, No. 1 East Chang An Ave, Tower W1, 7th Floor, Unit 1-7, |
Dong Cheng District, Beijing, 100738 | |
CHN4: | Ping An International Finance Centre, Room 1504-1505, 15th Floor, |
Tower A-101, 3-24 Floor, Xinyuan South Road, Chaoyang District, Beijing, | |
100027 | |
CHN5: | Unit B1303-1 & 1305, 13F Center Plaza, 161 Linhe Road West, Tianhe |
District Guangzhou | |
CHN6: | Unit 303, 3F, Tower 3 Kerry Plaza ,No.1 Zhong Xin Si Road, Fu Tian District, |
Shenzhen | |
CHN7: | Unit A-1, 5th Floor, No. 567, Tianshan West Road, Changning District, |
Shanghai | |
CHN8: | Intercontinental Center, 42F, 100 Yutong Road, Zhabei District, Shanghai, |
200070 | |
CHN9: | Room 319, 238 Jiangchangsan Road, Jing’an District, Shanghai |
CHN10: | Room 1201, Yinhe Building, Yuexiu Road, Hexi District, Tianjin, 300201 |
CHN11: | Building 2, Room No. 3895, Changjiang Avenue, No. 161, Changliang Farm, |
Chongming County, Shanghai | |
CHN12: | Floor 2, No.979, Yunhan Road, Nicheng Town, Pudong New District, |
Shanghai, 200000 | |
CHN13: | 4/F Block 3, No 999 Jingzhong Road, Changning District, Shanghai |
CHN14: | A0208, 1st Floor, Building 2, Yard 66, Yanfu Road, Yancun Tow, Fangshan |
District, Beijing | |
CHN15: | 16 Donghuangchenggen North Street, Beijing, 100717 |
CHN16: | Shenzhen International Chamber of Commerce Tower, Room 1801-1802, |
1805, Fuhua 3rd Road, Futian District, Shenzhen, 518048 | |
CHN17: | 5/F Unit A, Digital China Centre No. 567 Tianshan West Road, ChangNing |
District, Shanghai, 200335 | |
CHN18: | Room 726, 1256-1258 Wan Rong Road, Jing An District, Shanghai |
CHN19: | Oriental Plaza, No. 1 East Chang An Ave, Tower W1, 7th Floor, Unit |
12C, Dong Cheng District, Beijing, 100738 | |
Colombia | |
COL1: | Philippe Prietocarrizosa & Uria Abogados, Carrera 9 No. 74-08 Oficina 105, |
Bogota, d.c., 76600 | |
Denmark | |
DNK1: | Niels Jernes Vej 10, 9220, Aalborg East |
Egypt | |
EGY1: | Land Mark Office Building, 2nd Floor, 90th Street, City Center, 5th |
Settlement, New Cairo, Cairo |
Registered offices | |
Germany | |
DEU1: | Volklinger Strasse 4, 40219, Dusseldorf |
DEU2: | Bernhard-Wicki-Strasse 3/5 80636 München |
DEU3: | Heerdter Sandberg 30, 40549, Dusseldorf |
DEU4: | Stephanienstrasse 86, 76133 Karlsruhe |
DEU5: | Joseph-Schumpeter-Allee 33, 53227, Bonn |
DEU6: | Ohlauer Str. 43, Aufgang C, c/o Thunderbolt Collective, 10999, Berlin |
DEU7: | Johannstrasse 1, 40476 Düsseldorf |
Hong Kong | |
HNK1: | Room 1917, 19/F, Lee Garden One, 33 Hysan Avenue, Causeway Bay |
HNK2: | 1505,15th Floor, Tower A, Ping An International Finance Center |
HNK3: | 11/F Oxford House, Taikoo Place, 979 King’s Road, Quarry Bay |
HNK4: | 17th Floor, One Island East, Taikoo Place, 18 Westlands Road, Quarry Bay |
India | |
IND1: | 818, 8th Floor, Indraprakash Building, 21 Barakhamba Road, New Delhi, |
Delhi, 110001 | |
IND2: | Ascendas International Tech Park, Crest Building 12th Floor, Taramani |
Road, Taramani, Chennai, 600113 | |
Indonesia | |
IDN1: | APL Tower Central Park 26th Floor Unit T3 Jl. S. Parman Kav., 28, Grogol, |
Pertamburan Jakarta Barat 11470 | |
IDN2: | Gedung World Trade Center, 3 Lt. 20 Spaces JL Jend Sudirman Kav 29-31, |
Karet Kuningan, Setiabudi,Kota Adm. Jakarta Selatan, DKI Jakarta 12940 | |
Irish Republic | |
IRL1: | Riverside One, Sir John Rogerson’s Quay, Dublin 2, DO2 X576 |
IRL2: | 4th Floor, South Block, Rockfield Central, Dundrum, Dublin, D16 R6VO |
Israel | |
ISR1: | Meitar, Attorneys at Law, 16 Abba Hillel Road, Ramat Gan 5250608 |
Italy | |
ITA1: | Via Marostica 1, 20146, Milan |
ITA2: | Studio Colombo e Associati, Via San Damiano 9, 20122, Milan |
Japan | |
JPN1: | 1-9-15 Higashi-Azabu, Minato-Ku Tokyo 106-0044 |
JPN2: | 11F, Yaesu Central Tower, Tokyo Midtown Yaesu, 2-2-1 Yaesu Chuo-ku, |
Tokyo 104-0028 | |
Kingdom of Saudi Arabia | |
KSA1: | Riyadh, Financial Boulevard 13519, Al Aqeeq District |
Korea (Republic of) | |
KOR1: | 206 Noksapyeong-daero, Yongsan-gu, 140-861, Seoul |
KOR2: | 1622-24 Block A, Tera Tower II, 201 Songpa-daero, Songpa-gu, Seoul |
KOR3: | Story 2003 Bldg, 5, Baekjegobun-ro 9-gil, Songpa-gu, Seoul, 05561, Republic |
of Korea | |
KOR4: | 1602-03 Block A, Tera Tower II, 201 Songpa-daero, Songpa-gu, Seoul, Korea |
Macau | |
MAC1: | Rua De Xangai, No. 175 Edif. Associacao Comercial de Macau, 11 Andar, |
Bloco K | |
Malaysia | |
MYS1: | Suite 29-1, Level 29, Vertical Corporate, Tower B, Avenue 10, The Vertical, |
59200 Bangsar South City, Kuala Lumpur | |
Mexico | |
MEX1: | Avenida Paseo de la Reforma 243, Piso 15, Col. Cuauhtemoc, Mexico City, |
06500 | |
MEX2: | Av. Miguel Hidalgo y Costilla 1995, piso 6 oficina 10 , Ladron de Guevara, |
Guadalajara, Jalisco, 44600 | |
Netherlands | |
NLD1: | Radarweg 29, 1043 NX Amsterdam |
NLD2: | Hanzestraat 1, 7006RH Doetinchem |
New Zealand | |
NZL1: | Level 1, 138 The Terrace, P.O. Box 472, Wellington 6011 |
Philippines | |
PHL1: | Building H, 2nd Floor, U.P. Ayalaland TechnoHub, Commonwealth Avenue, |
Quezon City, Metro Manila, 1101 |
Registered offices | |
Poland | |
POL1: | Plac Grunwaldzki 23-27, 50-365 Wroclaw |
POL2: | Al. JJana Pawla II, 22, 00-133, Warszawa |
Singapore | |
SGP1: | 3 Killiney Road, #08-01, Winsland House 1, 239519 |
SGP2: | 9 Raffles Place, #26-01, Republic Plaza, 048619 |
South Africa | |
ZAF1: | Building 8, Country Club Estate Office Park, 21 Woodlands Drive, |
Woodmead, Gauteng, 2191 | |
Spain | |
ESP1: | C/ Josep Tarradellas 20-30, 1º / 20029, Barcelona |
Sweden | |
SWE1: | Aurorum 8, 977 75 Lulea |
Taiwan | |
TWN1: | RM. N905, 9F., No. 96, Sec. 2, Zhongshan N. Rd., Zhongshan Dist, Taipei, |
10449 | |
Thailand | |
THA1: | Sathorn Nakorn Building, Floor 32, No. 100/68-69 North Sathon Road, |
Silom, Bangrak, Bangkok, 10500 | |
THA2: | 14th Floor, CTI Tower, 191/70-73 Ratchadapisek Road, Khwaeng |
Klongtoey, Klongtoey, Bangkok, 10110 | |
THA3: | The Offices at Central World, Office R06, 999/9 Rama I Road, Pathumwan, |
Bangkok 10330 | |
Turkey | |
TUR1: | Maslak Mah. Bilim Sokak Sun Plaza Kat:13 Sisli-Maslak, Istanbul |
TUR2: | Tuyap Fuar ve Kongre Merkezi, Cumhuriyet Mah. Hadimkoy Yolu Cad. |
No:9/4 , 34500 Buyukcekmece, Istanbul | |
United Arab Emirates | |
UAE1: | Office 303, 3rd Floor Arjaan Office Tower Al Sufouh Complex, PO Box |
502425, Dubai Media City, Dubai | |
UAE2: | Al Sufouh Complex, Office nos. 404, 405, 406 & 407, Dubai Media City, |
Dubai | |
United Kingdom | |
GBR1: | 1-3 Strand, London, WC2N 5JR |
GBR2: | Gateway House, 28 The Quadrant, Richmond, Surrey, TW9 1DN |
GBR3: | Lexis House, 30 Farringdon Street, London, EC4A 4HH |
GBR4: | Global Reach, Dunleavy Drive, Cardiff, CF11 0SN |
GBR5: | 125 London Wall, London, EC2Y 5AS |
GBR6: | Biodata Innovation Centre Wellcome Genome Campus, Hinxton, |
Cambridge, CB10 1DR | |
United States | |
USA1: | 1000 Alderman Dr., Alpharetta, GA 30005 |
USA2: | 230 Park Ave, New York, NY 10169 |
USA3: | Suite 501, 1105 North Market St, Wilmington, DE 19801 |
USA4: | 1150 18th St, NW, Washington, DC 20036 |
USA5: | 9443 Springboro Pike, Miamisburg, OH 45342 |
USA6: | c/o Aon Insurance Managers (USA) Inc, 100 Bank Street, Suite 630 |
Burlington, Vermont 05401 | |
USA7: | #1095 Wilson, Ste 3, San Juan, PR 00907 |
USA8: | 2235 Gateway Access Point, Suite 300, Raleigh, NC, 27607 |
Vietnam | |
VIE1: | 2nd Floor, Kova Center, 92G-92H Nguyen Huu Canh Street, Ward no. 22, |
District. Binh Thanh, Ho Chi Minh City |
Company name | Registration number |
Aistemos Limited | 08644182 |
Butterworths Limited | 02826955 |
Cordery Compliance Limited | 07931532 |
Crediva Limited | 06567484 |
Interfolio UK Ltd (in dissolution) | 07820803 |
LNRS Data Services Holdings Limited | 00052790 |
Mack-Brooks Exhibitions Limited | 00967560 |
MLex Limited | 05488651 |
Offshore Europe (Management) Limited | 02318214 |
RE (HPL) Limited | 00598514 |
RE (RCB) Limited | 03396524 |
RE (SOE) Limited | 02330299 |
Reed Events Limited | 05893942 |
Reed Nominees Limited (in dissolution) | 00251020 |
RELX (Holdings) Limited | 05807690 |
RELX (Investments) plc | 05810043 |
RELX Overseas Holdings Limited | 09489059 |
REV Venture Partners Limited | 04226986 |
SciBite Limited | 07778456 |
Sustainable Energy Conferences Limited | 12157497 |
Tracesmart Limited | 03827062 |